LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

Search

Medpace Holdings Inc

Closed

SectorHealthcare

558.83 0.19

Overview

Share price change

24h

Current

Min

552.53

Max

564.37

Key metrics

By Trading Economics

Income

21M

111M

Sales

57M

660M

P/E

Sector Avg

38.377

77.671

Profit margin

16.841

Employees

6,200

EBITDA

32M

150M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

-0.07% downside

Market Stats

By TradingEconomics

Market Cap

175M

15B

Previous open

558.64

Previous close

558.83

News Sentiment

By Acuity

17%

83%

19 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Medpace Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 paź 2025, 15:15 UTC

Earnings

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Peer Comparison

Price change

Medpace Holdings Inc Forecast

Price Target

By TipRanks

-0.07% downside

12 Months Forecast

Average 557.5 USD  -0.07%

High 655 USD

Low 462 USD

Based on 8 Wall Street analysts offering 12 month price targets forMedpace Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

8 ratings

1

Buy

5

Hold

2

Sell

Technical Score

By Trading Central

300 / 302.88Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

19 / 374 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat